Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna MRNA revealed 20 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $987,565, and 11 were calls, valued at $337,840.
What’s The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $90.0 to $140.0 for Moderna over the last 3 months.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Moderna’s options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Moderna’s significant trades, within a strike price range of $90.0 to $140.0, over the past month.
Moderna Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | TRADE | BULLISH | 01/16/26 | $20.4 | $19.85 | $20.05 | $105.00 | $401.0K | 292 | 0 |
| MRNA | PUT | SWEEP | BULLISH | 01/16/26 | $13.5 | $13.5 | $13.5 | $90.00 | $278.1K | 926 | 2 |
| MRNA | PUT | SWEEP | BULLISH | 10/18/24 | $20.35 | $19.95 | $19.95 | $130.00 | $71.8K | 616 | 0 |
| MRNA | PUT | TRADE | NEUTRAL | 10/18/24 | $10.85 | $10.6 | $10.73 | $115.00 | $53.6K | 577 | 24 |
| MRNA | PUT | SWEEP | BEARISH | 01/17/25 | $9.6 | $9.35 | $9.4 | $100.00 | $47.0K | 2.9K | 0 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm’s mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Present Market Standing of Moderna
- Trading volume stands at 1,072,969, with MRNA’s price down by -1.24%, positioned at $116.85.
- RSI indicators show the stock to be may be oversold.
- Earnings announcement expected in 24 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
